Bioinformatics in new generation flavivirus vaccines
- PMID: 20467477
- PMCID: PMC2867002
- DOI: 10.1155/2010/864029
Bioinformatics in new generation flavivirus vaccines
Abstract
Flavivirus infections are the most prevalent arthropod-borne infections world wide, often causing severe disease especially among children, the elderly, and the immunocompromised. In the absence of effective antiviral treatment, prevention through vaccination would greatly reduce morbidity and mortality associated with flavivirus infections. Despite the success of the empirically developed vaccines against yellow fever virus, Japanese encephalitis virus and tick-borne encephalitis virus, there is an increasing need for a more rational design and development of safe and effective vaccines. Several bioinformatic tools are available to support such rational vaccine design. In doing so, several parameters have to be taken into account, such as safety for the target population, overall immunogenicity of the candidate vaccine, and efficacy and longevity of the immune responses triggered. Examples of how bio-informatics is applied to assist in the rational design and improvements of vaccines, particularly flavivirus vaccines, are presented and discussed.
Figures
Similar articles
-
A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available.Vaccine. 2014 Mar 10;32(12):1326-37. doi: 10.1016/j.vaccine.2014.01.040. Epub 2014 Jan 29. Vaccine. 2014. PMID: 24486372 Review.
-
Formalin-inactivated whole virus and recombinant subunit flavivirus vaccines.Adv Virus Res. 2003;61:395-418. doi: 10.1016/s0065-3527(03)61010-9. Adv Virus Res. 2003. PMID: 14714438 Review.
-
New developments in flavivirus vaccines with special attention to yellow fever.Curr Opin Infect Dis. 2005 Oct;18(5):387-94. doi: 10.1097/01.qco.0000178823.28585.ad. Curr Opin Infect Dis. 2005. PMID: 16148524 Review.
-
Traditional and novel approaches to flavivirus vaccines.Int J Parasitol. 2003 May;33(5-6):567-82. doi: 10.1016/s0020-7519(03)00063-8. Int J Parasitol. 2003. PMID: 12782056 Review.
-
Current status of flavivirus vaccines.Ann N Y Acad Sci. 2001 Dec;951:262-71. doi: 10.1111/j.1749-6632.2001.tb02702.x. Ann N Y Acad Sci. 2001. PMID: 11797783 Review.
Cited by
-
Rational design of West Nile virus vaccine through large replacement of 3' UTR with internal poly(A).EMBO Mol Med. 2021 Sep 7;13(9):e14108. doi: 10.15252/emmm.202114108. Epub 2021 Aug 5. EMBO Mol Med. 2021. PMID: 34351689 Free PMC article.
-
Virus-Like Particle Systems for Vaccine Development against Viruses in the Flaviviridae Family.Vaccines (Basel). 2019 Sep 20;7(4):123. doi: 10.3390/vaccines7040123. Vaccines (Basel). 2019. PMID: 31547131 Free PMC article. Review.
-
In silico analysis of an envelope domain III-based multivalent fusion protein as a potential dengue vaccine candidate.Clin Exp Vaccine Res. 2016 Jan;5(1):41-9. doi: 10.7774/cevr.2016.5.1.41. Epub 2016 Jan 27. Clin Exp Vaccine Res. 2016. PMID: 26866023 Free PMC article.
-
Computational vaccinology: an important strategy to discover new potential S. mansoni vaccine candidates.J Biomed Biotechnol. 2011;2011:503068. doi: 10.1155/2011/503068. Epub 2011 Oct 15. J Biomed Biotechnol. 2011. PMID: 22013383 Free PMC article. Review.
-
Systems biology approaches to new vaccine development.Curr Opin Immunol. 2011 Jun;23(3):436-43. doi: 10.1016/j.coi.2011.04.005. Epub 2011 May 11. Curr Opin Immunol. 2011. PMID: 21570272 Free PMC article. Review.
References
-
- Gaunt MW, Sall AA, de Lamballerie X, Falconar AKI, Dzhivanian TI, Gould EA. Phylogenetic relationships of flaviviruses correlate with their epidemiology, disease association and biogeography. Journal of General Virology. 2001;82, part 8:1867–1876. - PubMed
-
- Oya A, Kurane I. Japanese encephalitis for a reference to international travelers. Journal of Travel Medicine. 2007;14(4):259–268. - PubMed
-
- Blitvich BJ. Transmission dynamics and changing epidemiology of West Nile virus. Animal Health Research Reviews. 2008;9(1):71–86. - PubMed
-
- Halstead SB. Dengue. The Lancet. 2007;370(9599):1644–1652. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources